DOCSLIB.ORG

Bromodichloromethane

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Bromodichloromethane NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF BROMODICHLOROMETHANE (CAS NO. 75-27-4) IN MALE F344/N RATS AND FEMALE B6C3F1 MICE (DRINKING WATER STUDIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 February 2006 NTP TR 532 NIH Publication No. 06-4468 National Institutes of Health Public Health Service U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES FOREWORD The National Toxicology Program (NTP) is an interagency program within the Public Health Service (PHS) of the Department of Health and Human Services (HHS) and is headquartered at the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH). Three agencies contribute resources to the program: NIEHS/NIH, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (NIOSH/CDC), and the National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA) Established in 1978, the NTP is charged with coordinating toxicological testing activities, strengthening the science base in toxicology, developing and validating improved testing methods, and providing information about potentially toxic substances to health regulatory and research agencies, scientific and medical communities, and the public. The Technical Report series began in 1976 with carcinogenesis studies conducted by the National Cancer Institute. In 1981, this bioassay program was transferred to the NTP. The studies described in the Technical Report series are designed and conducted to characterize and evaluate the toxicologic potential, including carcinogenic activity, of selected substances in laboratory animals (usually two species, rats and mice). Substances selected for NTP toxicity and carcinogenicity studies are chosen primarily on the basis of human exposure, level of production, and chemical structure. The interpretive conclusions presented in NTP Technical Reports are based only on the results of these NTP studies. Extrapolation of these results to other species including characterization of hazards and risks to humans requires analyses beyond the intent of these reports. Selection per se is not an indicator of a substance’s carcinogenic potential. The NTP conducts its studies in compliance with its laboratory health and safety guidelines and Food and Drug Administration (FDA) Good Laboratory Practice Regulations, and must meet or exceed all applicable federal, state, and local health and safety regulations. Animal care and use are in accordance with the Public Health Service Policy on Humane Care and Use of Animals. Studies are subjected to retrospective quality assurance audits before being presented for public review. NTP Technical Reports are indexed in the NIH/NLM PubMed database and are available free of charge electronically on the NTP website (http://ntp.niehs.nih.gov) or in hardcopy upon request from the NTP Central Data Management group at [email protected] or (919) 541-3419. NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF BROMODICHLOROMETHANE (CAS NO. 75-27-4) IN MALE F344/N RATS AND FEMALE B6C3F1 MICE (DRINKING WATER STUDIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 February 2006 NTP TR 532 NIH Publication No. 06-4468 National Institutes of Health Public Health Service U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES 2 CONTRIBUTORS National Toxicology Program NTP Pathology Working Group Evaluated and interpreted results and reported findings Evaluated slides and prepared pathology report on rats (December 10, 2002) R.L. Melnick, Ph.D., Study Scientist P.H. Long, D.V.M., Ph.D., Chairperson R.A. Herbert, D.V.M., Ph.D., Study Pathologist Pathology Associates, A Charles River Company D.W. Bristol, Ph.D. Laboratories, Inc. J.R. Bucher, Ph.D. N. Allison, D.V.M. J.R. Hailey, D.V.M. Experimental Pathology Laboratories, Inc. G.E. Kissling, Ph.D. R.A. Herbert, D.V.M., Ph.D. R.R. Maronpot, D.V.M. National Toxicology Program F.M. Parham, Ph.D. G.D. Hill, D.V.M., Ph.D. S.D. Peddada, Ph.D. National Toxicology Program C.S. Smith, Ph.D. A. Nyska, D.V.M. National Toxicology Program G.S. Travlos, D.V.M. G. Pearse, B.V.M.&S. K.L. Witt, M.S. National Toxicology Program J.C. Peckham, D.V.M., M.S., Ph.D. Southern Research Institute Experimental Pathology Laboratories, Inc. Conducted studies and evaluated pathology findings C. Picut, V.M.D., J.D. Integrated Laboratory Systems C.D. Hébert, Ph.D., Principal Investigator (2-Year Studies) W.R. Richter, D.V.M., M.S., Principal Investigator Evaluated slides and prepared pathology report on mice (October 24, 2002) (2-Year Studies) J.D. Prejean, Ph.D., Principal Investigator (3-Week Studies) P.H. Long, D.V.M., Ph.D., Chairperson J.E. Heath, D.V.M. Pathology Associates, A Charles River Company P.R. Farnell, D.V.M., M.S., Ph.D. K.Y. Cimon, D.V.M., M.S. R.B. Thompson, D.V.M., Ph.D. Experimental Pathology Laboratories, Inc. R.A. Herbert, D.V.M., Ph.D. Experimental Pathology Laboratories, Inc. National Toxicology Program G.D. Hill, D.V.M., Ph.D. Provided pathology review National Toxicology Program D.E. Malarkey, D.V.M., Ph.D. M.H. Hamlin, II, D.V.M., Principal Investigator National Toxicology Program N. Allison, D.V.M. G. Pearse, B.V.M.&S. K.Y. Cimon, D.V.M., M.S. National Toxicology Program J.C. Peckham, D.V.M., M.S., Ph.D. J.C. Peckham, D.V.M., M.S., Ph.D. J.C. Seely, D.V.M. Experimental Pathology Laboratories, Inc. J.C. Seely, D.V.M. Dynamac Corporation Experimental Pathology Laboratories, Inc. Prepared quality assurance audits Y. Tani, D.V.M., Ph.D., Observer National Toxicology Program S. Brecher, Ph.D., Principal Investigator Biotechnical Services, Inc. Constella Group Prepared Technical Report Provided statistical analyses S.R. Gunnels, M.A., Principal Investigator P.W. Crockett, Ph.D., Principal Investigator L.M. Harper, B.S. L.J. Betz, M.S. P.A. Gideon, B.A. K.P. McGowan, M.B.A. E.S. Rathman, M.S. J.T. Scott, M.S. D.C. Serbus, Ph.D. 3 CONTENTS ABSTRACT . 5 EXPLANATION OF LEVELS OF EVIDENCE OF CARCINOGENIC ACTIVITY . 8 TECHNICAL REPORTS REVIEW SUBCOMMITTEE . 9 SUMMARY OF TECHNICAL REPORTS REVIEW SUBCOMMITTEE COMMENTS . 10 INTRODUCTION . 11 MATERIALS AND METHODS . 21 RESULTS . 29 DISCUSSION AND CONCLUSIONS . 45 REFERENCES . 53 APPENDIX A Summary of Lesions in Male Rats in the 2-Year Drinking Water Study of Bromodichloromethane . 61 APPENDIX B Summary of Lesions in Female Mice in the 2-Year Drinking Water Study of Bromodichloromethane . 101 APPENDIX C Genetic Toxicology . 143 APPENDIX D Clinical Pathology Results . 163 APPENDIX E Organ Weights and Organ-Weight-to-Body-Weight Ratios . 167 APPENDIX F Chemical Characterization and Dose Formulation Studies . 171 APPENDIX G Water and Compound Consumption in the 2-Year Drinking Water Studies of Bromodichloromethane . 185 APPENDIX H Ingredients, Nutrient Composition, and Contaminant Levels in NIH-2000 Rat and Mouse Ration . 189 APPENDIX I Sentinel Animal Program . 193 APPENDIX J Single-Dose Toxicokinetic Studies in F344/N Rats and B6C3F1 Mice . 197 APPENDIX K Physiologically Based Pharmacokinetic Model and Dose-Response Analyses . 211 4 Bromodichloromethane, NTP TR 532 SUMMARY Background Bromodichloromethane occurs as a by-product of the chlorination of drinking water. In earlier studies, bromodichloromethane caused cancer of the intestine and kidney in rats and of the liver and kidney in mice when doses of the chemical dissolved in corn oil were deposited in the stomachs of the animals. We studied the effects of bromodichloromethane in drinking water on male rats and female mice to see if the same effects occurred. Methods We gave drinking water containing 175, 350, or 700 mg of bromodichlomethane per liter of water to groups of 50 male rats and female mice for two years. Control animals received the same tap water with no chemical added. At the end of the study tissues from more than 40 sites were examined for every animal. Results Body weights and survival of animals receiving bromodichloromethane were similar to those of the control animals. No cancers or nonneoplastic lesions occurred more frequently as a result of exposure to bromodichloromethane in drinking water. Conclusions We conclude that bromodichloromethane in the drinking water did not cause cancer in male rats or female mice. 5 ABSTRACT Br H C Cl Cl BROMODICHLOROMETHANE CAS No. 75-27-4 Chemical Formula: CHBrCl2 Molecular Weight: 163.83 Synonym: Dichlorobromomethane Bromodichloromethane is a by-product of the chlorina­ bromodichloromethane (equivalent to average daily tion of drinking water. It is formed by the halogen sub­ doses of approximately 0, 6, 12, 20, 38, or 71 mg bro­ stitution and oxidation reactions of chlorine with modichloromethane/kg body weight) in drinking water naturally occurring organic matter (e.g., humic or for 3 weeks. All rats survived to the end of the study. fulvic acids) in water containing bromide. The mean body weight gains of 350 and 700 mg/L rats Bromodichloromethane has been shown to be carcino­ were significantly less than that of the controls. genic at multiple sites in rats (large intestine and kidney) Concentration-related decreases in water consumption and in mice (liver and kidney) after administration by were evident during the first week on study. Relative gavage in corn oil. To further characterize its dose- kidney weights of rats in the 175, 350, and 700 mg/L response relationships for evaluations of human risk, groups were significantly greater than that of the con­ bromodichloromethane was nominated to the NTP by trols. There were no significant chemical-related the United States Environmental Protection Agency for histopathological changes. toxicity and carcinogenicity studies in rats and mice by drinking water exposure. Male F344/N rats and female B6C3F1 mice were exposed to bromodichloromethane 3-WEEK STUDY IN MICE (greater than 98% pure) in drinking water for 3 weeks or Groups of 10 female B6C3F1 mice were exposed to tar­ 2 years.
Load more

Recommended publications
  • Disinfection Byproducts in Chlorinated Drinking Water
    International Journal of Water and Wastewater Treatment SciO p Forschene n HUB for Sc i e n t i f i c R e s e a r c h ISSN 2381-5299 | Open Access RESEARCH ARTICLE Volume 4 - Issue 2 | DOI: http://dx.doi.org/10.16966/2381-5299.156 Disinfection Byproducts in Chlorinated Drinking Water Malia Vester1, Hany F Sobhi2 and Mintesinot Jiru1* 1Department of Natural Sciences, Coppin State University, Maryland, USA 2Center for Organic Synthesis, Department of Natural Sciences, Coppin State University, Maryland, USA *Corresponding author: Mintesinot Jiru, Department of Natural Sciences, Coppin State University, Maryland, USA, Tel: 410-951-4139; E-mail: [email protected] Received: 07 Jul, 2018 | Accepted: 14 Nov, 2018 | Published: 20 Nov, 2018 Citation: Vester M, Sobhi HF, Jiru M (2018) Disinfection Byproducts in Chlorinated Drinking Water. Int J Water Wastewater Treat 4(2): dx.doi. org/10.16966/2381-5299.156 Copyright: © Vester M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Trihalomethanes (THMs) are disinfection byproducts formed through the reaction of chlorine and organic matter. There are four forms of Trihalomethanes: chloroform, bromoform, dibromochloromethane and bromodichloromethane. Studies have shown that chloroform, a principal disinfection byproduct, is carcinogenic in rodents. Although the presence of these hazardous materials are constantly being monitored by Water Treatment Plant and the Environmental Protection Agency (EPA), they continue to be present at an unpredictable levels and the full effects of these byproducts are not fully understood.
    [Show full text]
  • Toxicological Profile for Bromodichloromethane
    BROMODICHLOROMETHANE 89 CHAPTER 5. POTENTIAL FOR HUMAN EXPOSURE 5.1 OVERVIEW Bromodichloromethane has been identified in at least 238 of the 1,854 hazardous waste sites that have been proposed for inclusion on the EPA National Priorities List (NPL) (ATSDR 2017). However, the number of sites in which bromodichloromethane has been evaluated is not known. The number of sites in each state is shown in Figure 5-1. Of these sites, 233 are located within the United States, 2 are located in the Virgin Islands, and 3 are located in Puerto Rico (not shown). Figure 5-1. Number of NPL Sites with Bromodichloromethane Contamination • The most likely route of exposure for the general public to bromodichloromethane is through ingestion, inhalation, and dermal contact of chlorinated drinking water. • A median bromodichloromethane intake of 2.8–4.2 µg/day from drinking water has been estimated; inhalation and dermal exposure would add to this daily intake. BROMODICHLOROMETHANE 90 5. POTENTIAL FOR HUMAN EXPOSURE • Bromodichloromethane is formed as a byproduct of water disinfection methods using chlorination. This is the primary source of bromodichloromethane in the environment. • Its principal use is as a chemical intermediate for organic synthesis and as a chemical reagent. • Volatilization is an important fate process. Bromodichloromethane evaporates from sources and enters the environment as a gas, which is slowly broken down in air. Residual bromodichloromethane may be broken down slowly by bacteria. • In the atmosphere, bromodichloromethane is thought to undergo slow degradation through oxidative pathways, with a half-life of about 2–3 months. 5.2 PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL 5.2.1 Production The principal anthropogenic source of bromodichloromethane is its unintentional formation as a byproduct during the chlorination of water containing organic materials and bromide.
    [Show full text]
  • An Automated Purge and Trap Gas Chromatography- Mass Spectrometry System for the Sensitive Shipboard Analysis of Volatile Organi
    J. Sep. Sci. 2001, 24, 97–103 Hashimoto, Tanaka, Yamashita, Maeda97 Shinya Hashimotoa), An automated purge and trap gas chromatography- Toshiyuki Tanakab), mass spectrometry system for the sensitive Nobuyoshi Yamashitab), Tsuneaki Maedac) shipboard analysis of volatile organic compounds in seawater a) Department of Ocean Sciences, Tokyo University of We developed an automated purge and trap unit connected to a gas chromatograph- Fisheries, 4-5-7 Konan, Minato- mass spectrometer for shipboard determination of unstable volatile organic com- ku, Tokyo 108±8477, Japan pounds in seawater. The device used a small column for the rapid desorption of ad- b) National Institute for sorbed compounds, thus eliminating the need for post-desorption cryofocusing. The Resources and Environment, a 16-3 Onogawa, Tsukuba, repeatability (relative standard deviation, RSD; n = 7) was typically 5%. The detection Ibaraki 305±8569, Japan limits were 0.1–4.3 pM for chloromethane, bromomethane, dichloromethane, iodo- c) DKK Corporation, 4-13-14 methane, dimethyl sulfide, iodoethane, isoprene, bromochloromethane, chloroform, Kichijoji Kitamachi, Musashino- tetrachloromethane, dibromomethane, bromodichloromethane, iodopropane, chlor- shi, Tokyo 108-0001, Japan oiodomethane, dimethyl disulfide, dibromochloromethane, bromoform, and diiodo- methane. To investigate the stability of seawater samples, we obtained a concentra- tion-time profile of volatile organic compounds using this method during the incubation of a seawater sample with and without the addition of HgCl2 in the dark at 48C. We found shipboard determination to be suitable and essential for the determination of un- stable compounds such as dimethyl sulfide in seawater, as the concentration of di- methyl sulfide increased considerably during the incubation of a seawater sample both with and without the addition of HgCl2.
    [Show full text]
  • Evaluating Analytical Methods for Detecting Unknown Chemicals in Recycled Water
    PROJECT NO. 4992 Evaluating Analytical Methods for Detecting Unknown Chemicals in Recycled Water Evaluating Analytical Methods for Detecting Unknown Chemicals in Recycled Water Prepared by: Keith A. Maruya Charles S. Wong Southern California Coastal Water Research Project Authority 2020 The Water Research Foundation (WRF) is a nonprofit (501c3) organization which provides a unified source for One Water research and a strong presence in relationships with partner organizations, government and regulatory agencies, and Congress. The foundation conducts research in all areas of drinking water, wastewater, stormwater, and water reuse. The Water Research Foundation’s research portfolio is valued at over $700 million. The Foundation plays an important role in the translation and dissemination of applied research, technology demonstration, and education, through creation of research‐based educational tools and technology exchange opportunities. WRF serves as a leader and model for collaboration across the water industry and its materials are used to inform policymakers and the public on the science, economic value, and environmental benefits of using and recovering resources found in water, as well as the feasibility of implementing new technologies. For more information, contact: The Water Research Foundation Alexandria, VA Office Denver, CO Office 1199 North Fairfax Street, Suite 900 6666 West Quincy Avenue Alexandria, VA 22314‐1445 Denver, Colorado 80235‐3098 Tel: 571.384.2100 Tel: 303.347.6100 www.waterrf.org [email protected] ©Copyright 2020 by The Water Research Foundation. All rights reserved. Permission to copy must be obtained from The Water Research Foundation. WRF ISBN: 978‐1‐60573‐503‐0 WRF Project Number: 4992 This report was prepared by the organization(s) named below as an account of work sponsored by The Water Research Foundation.
    [Show full text]
  • Trihalomethanes in Drinking-Water
    WHO/SDE/WSH/05.08/64 English only Trihalomethanes in Drinking-water Background document for development of WHO Guidelines for Drinking-water Quality WHO information products on water, sanitation, hygiene and health can be freely downloaded at: http://www.who.int/water_sanitation_health/ © World Health Organization 2005 This document may be freely reviewed, abstracted, reproduced and translated in part or in whole but not for sale or for use in conjunction with commercial purposes. Inquiries should be addressed to: [email protected]. The designations employed and the presentation of the material in this document do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. Preface One of the primary goals of WHO and its member states is that “all people, whatever their stage of development and their social and economic conditions, have the right to have access to an adequate supply of safe drinking water.” A major WHO function to achieve such goals is the responsibility “to propose ..
    [Show full text]
  • Maine Remedial Action Guidelines (Rags) for Contaminated Sites
    Maine Department of Environmental Protection Remedial Action Guidelines for Contaminated Sites (RAGs) Effective Date: May 1, 2021 Approved by: ___________________________ Date: April 27, 2021 David Burns, Director Bureau of Remediation & Waste Management Executive Summary MAINE DEPARTMENT OF ENVIRONMENTAL PROTECTION 17 State House Station | Augusta, Maine 04333-0017 www.maine.gov/dep Maine Department of Environmental Protection Remedial Action Guidelines for Contaminated Sites Contents 1 Disclaimer ...................................................................................................................... 1 2 Introduction and Purpose ............................................................................................... 1 2.1 Purpose ......................................................................................................................................... 1 2.2 Consistency with Superfund Risk Assessment .............................................................................. 1 2.3 When to Use RAGs and When to Develop a Site-Specific Risk Assessment ................................. 1 3 Applicability ................................................................................................................... 2 3.1 Applicable Programs & DEP Approval Process ............................................................................. 2 3.1.1 Uncontrolled Hazardous Substance Sites ............................................................................. 2 3.1.2 Voluntary Response Action Program
    [Show full text]
  • Interagency Committee on Chemical Management
    DECEMBER 14, 2018 INTERAGENCY COMMITTEE ON CHEMICAL MANAGEMENT EXECUTIVE ORDER NO. 13-17 REPORT TO THE GOVERNOR WALKE, PETER Table of Contents Executive Summary ...................................................................................................................... 2 I. Introduction .......................................................................................................................... 3 II. Recommended Statutory Amendments or Regulatory Changes to Existing Recordkeeping and Reporting Requirements that are Required to Facilitate Assessment of Risks to Human Health and the Environment Posed by Chemical Use in the State ............................................................................................................................ 5 III. Summary of Chemical Use in the State Based on Reported Chemical Inventories....... 8 IV. Summary of Identified Risks to Human Health and the Environment from Reported Chemical Inventories ........................................................................................................... 9 V. Summary of any change under Federal Statute or Rule affecting the Regulation of Chemicals in the State ....................................................................................................... 12 VI. Recommended Legislative or Regulatory Action to Reduce Risks to Human Health and the Environment from Regulated and Unregulated Chemicals of Emerging Concern ..............................................................................................................................
    [Show full text]
  • Global Warming Potentials (Gwps), and Global Temperature Change Potentials (Gtps)
    APPENDIX A SUMMARY OF ABUNDANCES, LIFETIMES, OZONE DEPLETION POTENTIALS (ODPS), RADIATIVE EFFICIENCIES (RES), GLOBAL WARMING POTENTIALS (GWPS), AND GLOBAL TEMPERATURE CHANGE POTENTIALS (GTPS) Lead Author J.B. Burkholder Contributors Ø. Hodnebrog V.L. Orkin 2 Cover photo: Experimental apparatus used in fundamental kinetic and photochemical laboratory studies. Lab- oratory measurements provide key input to the derivation of the parameters reported in this appendix. Photo: W. von Dauster, NOAA. APPENDIX A SUMMARY OF ABUNDANCES, LIFETIMES, OZONE DEPLETION POTENTIALS (ODPS), RADIATIVE EFFICIENCIES (RES), GLOBAL WARMING POTENTIALS (GWPS), AND GLOBAL TEMPERATURE CHANGE POTENTIALS (GTPS) CONTENTS APPENDIX A: INTRODUCTION . 1 APPENDIX A: SUMMARY OF ABUNDANCES, LIFETIMES, ODPS, RES, GWPS, AND GTPS . 2 Hydrocarbons . 2 Oxygenated Hydrocarbons . 2 Chlorofluorocarbons . 2 Hydrochlorofluorocarbons . 4 Hydrofluorocarbons . 18 Unsaturated Hydrofluorocarbons . 20 Chlorocarbons and Hydrochlorocarbons . 22 Unsaturated Hydrochlorocarbons and Chlorocarbons . 24 Unsaturated Chlorofluorocarbons and Hydrochlorofluorocarbons . 24 Bromocarbons, Hydrobromocarbons and Halons . 24 Unsaturated Bromofluorocarbons . 26 Unsaturated Bromochlorofluorocarbons . 26 Fully Fluorinated Species . 26 Halogenated Ethers . 28 Fluoroesters . 32 Halogenated Alcohols . 34 Halogenated Ketones . 36 Iodocarbons . 36 Special Compounds . 36 Table Heading Footnotes . 38 Abundance Footnotes . 39 Lifetime Footnotes . 39 ODP Footnotes . 42 RE, GWP, and GTP Footnotes . 43 REFERENCES . 44 This
    [Show full text]
  • Burske Norbert W 195708 Phd
    "In presenting the dissertation as a partial fulfillment of the requirements for an advanced degree from the Georgia Institute of Technology, I agree that the Library of the Institution shall make it available for inspection and circulation in accordance with its regulations governing materials of this type. I agree that permission to copy from, or to publish from, this dissertation may be granted by the professor under whose direction it was written, or, in his absence, by the dean of the Graduate Division when such copying or publication is solely for scholarly purposes and does not involve potential financial gain. It is understood that any copying from, or publication of, this dissertation which involves potential financial gain will not be allowed without written permission. n It THE KINETICS OF THE BASE-CATALYZED DEUTERIUM EXCHANGE OF SOME HALOFORMS IN AQUEOUS SOLUTION A THESIS Presented to the Faculty of the Graduate Division Georgia Institute of Technology In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the School of Chemistry By Norbert William Burske June 1957 1< THE KINETICS OF THE BASE-CATALYZED DEUTERIUM EXCHANGE OF SOME HALOFORMS IN AQUEOUS SOLUTION Approved, J I ki Jack Hine I ,r Lod D. Frashier Erlft.Edg Grovenstein, Jr. Date Approved by Chairman, ii ACKNOWLEDGEMENT The author wishes to gratefully acknowledge his in- debtedness to Dr. J. Hine for invaluable guidance and without his aid this project would never have been completed. Also, the author is indebted to the Atomic Energy Commission and the Office of Ordnance Research, U. S. Army for sponsoring assistantships.
    [Show full text]
  • Process for the Production of 4-Chloroacetyl Chloride, 4
    (19) & (11) EP 2 518 043 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 31.10.2012 Bulletin 2012/44 C07C 51/58 (2006.01) C07C 67/14 (2006.01) C07C 231/02 (2006.01) C07C 59/21 (2006.01) (2006.01) (21) Application number: 11003510.2 C07C 69/63 (22) Date of filing: 29.04.2011 (84) Designated Contracting States: (71) Applicant: Lonza Ltd AL AT BE BG CH CY CZ DE DK EE ES FI FR GB 4052 Basel (CH) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (72) Inventor: The designation of the inventor has not Designated Extension States: yet been filed BA ME (54) Process for the production of 4- chloroacetyl chloride, 4-chloroacetic acid esters, amides and imides (57) The invention relates to process for the contin- acetoacetyl chloride. uous production of 4-chloroacetoacetyl chloride, com- prising the steps of The invention also relates to a process for the production (a) feeding diketene and chlorine into a thin film reactor of 4-chloroacetic acid ester, 4-chloroacetic acid amide or and 4-chloroacetic acid imide from 4- chloroacetoacetyl chlo- (b) reacting the diketene and chlorine to obtain 4- chloro- ride obtained according to the inventive process. EP 2 518 043 A1 Printed by Jouve, 75001 PARIS (FR) 1 EP 2 518 043 A1 2 Description reactors and equipment and more energy for cooling. When increasing the volume of the reactor, the yield [0001] The invention relates to processes for the pro- dropped "drastically" andthe selectivity was relatively low duction of 4-chloroacetoacetyl chloride, 4-chloroacetic (US 4,473,508, example 7).
    [Show full text]
  • Drinking Water Criteria Document for Brominated Trihalomethanes
    United States Office of Science and EPA-822-R-05-011 Environmental Technology November 15, 2005 Protection Agency Washington, D.C. EPA Office of Water DRINKING WATER CRITERIA DOCUMENT FOR BROMINATED TRIHALOMETHANES Prepared for Health and Ecological Criteria Division Office of Science and Technology Office of Water U.S. Environmental Protection Agency Washington, D.C. 20460 under EPA Contract No. 68-C-02-206 Work assignment 3-16 by Syracuse Research Corporation 6225 Running Ridge Road North Syracuse, NY 13212 Under subcontract to The Cadmus Group, Inc. 135 Beaver Street Waltham, MA 02452 FOREWORD Section 1412 (b) (3) (A) of the Safe Drinking Water Act, as amended in 1986, requires the Administrator of the Environmental Protection Agency to publish Maximum Contaminant Level Goals (MCLGs) and promulgate National Primary Drinking Water Regulations for each contaminant, which, in the judgment of the Administrator, may have an adverse effect on public health and which is known or anticipated to occur in public water systems. The MCLG is nonenforceable and is set at a level at which no known or anticipated adverse health effects in humans occur and which allows for an adequate margin of safety. Factors considered in setting the MCLG include health effects data and sources of exposure other than drinking water. This document provides the health effects basis to be considered in establishing the MCLGs for brominated trihalomethanes found in chlorinated drinking water. To achieve this objective, data on pharmacokinetics, human exposure, acute and chronic toxicity to animals and humans, epidemiology and mechanisms of toxicity were evaluated. Specific emphasis is placed on literature data providing dose-response information.
    [Show full text]
  • Defining Potential Chemical Peaks and Management Options
    PROJECT NO. 4991 Defining Potential Chemical Peaks and Management Options Defining Potential Chemical Peaks and Management Options Prepared by: Jean Debroux Kennedy Jenks Consultants Megan H. Plumlee Orange County Water District Shane Trussell Trussell Technologies, Inc. Co-sponsored by: California State Water Resources Control Board 2021 The Water Research Foundation (WRF) is a nonprofit (501c3) organization which provides a unified source for One Water research and a strong presence in relationships with partner organizations, government and regulatory agencies, and Congress. The foundation conducts research in all areas of drinking water, wastewater, stormwater, and water reuse. The Water Research Foundation’s research portfolio is valued at over $700 million. WRF plays an important role in the translation and dissemination of applied research, technology demonstration, and education, through creation of research-based educational tools and technology exchange opportunities. WRF serves as a leader and model for collaboration across the water industry and its materials are used to inform policymakers and the public on the science, economic value, and environmental benefits of using and recovering resources found in water, as well as the feasibility of implementing new technologies. For more information, contact: The Water Research Foundation 1199 North Fairfax Street, Suite 900 6666 West Quincy Avenue Alexandria, VA 22314-1445 Denver, Colorado 80235-3098 www.waterrf.org P 571.384.2100 P 303.347.6100 [email protected] ©Copyright 2021 by The Water Research Foundation. All rights reserved. Permission to copy must be obtained from The Water Research Foundation. WRF ISBN: 978-1-60573-555-9 WRF Project Number: 4991 This report was prepared by the organization(s) named below as an account of work sponsored by The Water Research Foundation.
    [Show full text]